EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease

Franziska Oliveri iD, Linda Neher, Ronja Pscheid iD, Isabel Sewald, Sowmya Gowdavally, Annika C Betzler iD, Jaqueline Hallitsch, Jens Greve iD, Simon Laban, Sebastian Schmid iD, Thomas K Hoffmann iD, Patrick J Schuler iD und 1 weitere

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-024-03907-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Franziska Oliveri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections, Head and Neck Neoplasms, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universitätsklinikum Ulm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a poor prognosis for survival. Risk factors include alcohol and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor immune responses immunotherapeutic approaches are approved for recurrent metastatic disease but only approx. 20% of patients respond to checkpoint blockade of the PD-1/PD-L1 axis. Therefore, preclinical research is needed to better understand molecular and cellular processes and to identify new therapeutic targets. Immunocompetent mouse models can serve these purposes but only few are currently available for HPV-positive HNSCC. Here, we established a mouse cell line overexpressing the oncogenes E6 / E7 of the HPV16 genome as well as a constitutively active form of H-Ras and studied the anti-tumor immune response upon orthotopic tumor growth at the floor of the mouth. Moreover, we analyzed the same immunoregulatory pathways in samples of HPV-positive cancer patients. T cells in the tumor of mice and humans exhibited high expression of CD39 and CD73, two ectoenzymes involved in the production of immunosuppressive adenosine from ATP, along with increased expression of PD-1, LAG-3 and GITR. Additionally, B cell responses were elevated in tumor-bearing mice, seen as an increase of germinal center, immunoregulatory marginal zone and follicular B cell subtypes. Taken together, this study suggests that the generated mouse model shares characteristics with human disease and can thus be used as a platform to study anti-tumor responses in HPV-positive HNSCC which will help to identify novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckPapillomavirus InfectionsHead and Neck NeoplasmsDisease Models, AnimalAdaptive ImmunityAnimalsMiceHumansOncogene Proteins, ViralHuman papillomavirus 16Papillomavirus E7 ProteinsApyraseCell Line, TumorRepressor ProteinsFemale5'-NucleotidaseAntigens, CDMice, Inbred C57BL

Stichwörter der Autor:innen

HPVHead and neck cancerImmune checkpointsTumor-infiltrating lymphocytes

Substanzen

Oncogene Proteins, ViralPapillomavirus E7 ProteinsCD39 antigenApyraseRepressor ProteinsE6 protein, Human papillomavirus type 16oncogene protein E7, Human papillomavirus type 165'-NucleotidaseAntigens, CD

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
  • Department of Anesthesiology and Intensive Care Medicine, Ulm University Medical Center, Ulm, Germany.
  • Department of Otorhinolaryngology, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany. cornelia.brunner@uniklinik-ulm.de.
  • Core Facility Immune Monitoring, Ulm University Medical Faculty, Ulm, Germany. cornelia.brunner@uniklinik-ulm.de.

ORCID-Profile: Franziska Oliveri, Ronja Pscheid, Annika C Betzler, Jens Greve, Sebastian Schmid, Thomas K Hoffmann, Patrick J Schuler, Cornelia Brunner

Förderung

  • Deutsche Forschungsgemeinschaft
  • Universitätsklinikum Ulm

Zitieren

APA

Oliveri, F., Neher, L., Pscheid, R., Sewald, I., Gowdavally, S., Betzler, A. C., Hallitsch, J., Greve, J., Laban, S., Schmid, S., Hoffmann, T. K., Schuler, P. J., & Brunner, C. (2025). Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03907-y

Vancouver

Oliveri F, Neher L, Pscheid R, Sewald I, Gowdavally S, Betzler AC, et al. Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-024-03907-y

BibTeX
@article{Oliveri2025,
  author = {Oliveri, Franziska and Neher, Linda and Pscheid, Ronja and Sewald, Isabel and Gowdavally, Sowmya and Betzler, Annika C and Hallitsch, Jaqueline and Greve, Jens and Laban, Simon and Schmid, Sebastian and Hoffmann, Thomas K and Schuler, Patrick J and Brunner, Cornelia},
  title = {Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-024-03907-y}
}
Kostenlos starten →